Authors

  • Nadirova Y.I., Tursunova L.D., Keldiyarova D.O.

Keywords:

cardiorenal syndrome; chronic kidney disease; chronic heart failure; osteoporosis; VDR gene; densitometry; FRAX.

References

1. Goto N.A., Weststrate A.C.G., Oosterlaan F.M. et al. The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis. Osteoporosis International, 2020, vol. 31, no. 1, pp. 13–29. https://doi.org/10.1007/s00198-019-05190-5

2. Haarhaus M., Jørgensen H.S., Bacchetta J. et al. Bone turnover markers in the management of CKD-associated osteoporosis: a European consensus. Nephrology Dialysis Transplantation, 2026, vol. 41, no. 7, pp. 1357–1375. https://doi.org/10.1093/ndt/gfag033

3. Inker L.A., Eneanya N.D., Coresh J. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 2021, vol. 385, no. 19, pp. 1737–1749. https://doi.org/10.1056/NEJMoa2102953

4. Jančuška A., Kužma M., Králik R. et al. Skeletal changes and vascular calcifications in chronic kidney disease: two connected cups. Bratislava Medical Journal, 2025, vol. 126, no. 5, pp. 637–648. https://doi.org/10.1007/s44411-025-00087-8

5. Jia F., Sun R.F., Li Q.H. et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genetic Testing and Molecular Biomarkers, 2013, vol. 17, no. 1, pp. 30–34. https://pubmed.ncbi.nlm.nih.gov/23134477/

6. Jørgensen H.S., Vervloet M., Cavalier E. et al. The role of nutritional vitamin D in chronic kidney disease–mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation — a European consensus statement. Nephrology Dialysis Transplantation, 2025, vol. 40, no. 4, pp. 797–822. https://doi.org/10.1093/ndt/gfae293

7. Kamiński A., Bogacz A., Niezgoda-Nowak J.T. et al. The VDR rs1544410 and rs11568820 variants and the risk of osteoporosis in the Polish population. International Journal of Molecular Sciences, 2025, vol. 26, no. 2, art. 481. https://doi.org/10.3390/ijms26020481

8. Kampka Z., Czapla D., Wojakowski W., Stanek A. Vitamin D supplementation in heart failure — confusion without a cause? Nutrients, 2025, vol. 17, no. 11, art. 1839. https://doi.org/ 10.3390/nu17111839

9. Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis International, 2008, vol. 19, no. 4, pp. 385–397.

10. Ketteler M., Evenepoel P., Holden R.M. et al. Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 2025, vol. 107, pp. 405–423. https://doi.org/10.1016/j.kint.2024. 11.013

11. LeBoff M.S., Greenspan S.L., Insogna K.L. et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 2022, vol. 33, no. 10, pp. 2049–2102. https://doi.org/10.1007/s00198-021-05900-y

12. Levin A., Ahmed S.B., Carrero J.J. et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International, 2024, vol. 105, no. 4, pp. 684–701. https:// doi.org/10.1016/j.kint.2023.10.016

13. Liu Y., Zhang Z.X., Fu C.S. et al. Association of aberrant mineral metabolic markers with fracture risk in chronic kidney disease: a comprehensive meta-analysis. BMC Nephrology, 2025, vol. 26, art. 68. https://doi.org/10.1186/s12882-025-03992-w

14. McDonagh T.A., Metra M., Adamo M. et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2023, vol. 44, no. 37, pp. 3627–3639. https://doi.org/10.1093/eurheartj/ehad195

15. Mo C., Ke J., Zhao D. et al. Role of the renin–angiotensin–aldosterone system in bone metabolism. Journal of Bone and Mineral Metabolism, 2020, vol. 38, no. 6, pp. 772–779. https:// doi.org/10.1007/s00774-020-01132-y

16. Moustaki M., Paschou S.A., Palioura E. et al. Chronic kidney disease: from mineral dysregulation to bone and cardiovascular disease. Journal of Endocrinological Investigation, 2026, online ahead of print. https://doi.org/10.1007/s40618-026-02955-8

17. Nakagawa Y., Komaba H. Roles of parathyroid hormone and fibroblast growth factor 23 in advanced chronic kidney disease. Endocrinology and Metabolism, 2024, vol. 39, no. 3, pp. 407–415. https://doi.org/10.3803/EnM.2024.1978

18. Rangaswami J., Bhalla V., Blair J.E. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies. A scientific statement from the American Heart Association. Circulation, 2019, vol. 139, pp. e840–e878. https://doi.org/10.1161/CIR.00000000000 00664

19. Rashid A., Hauge S.C., Nielsen B.R. et al. High prevalence of sarcopenia, osteoporosis and osteosarcopenia in patients with chronic kidney disease compared with healthy controls. Osteoporosis International, 2026, vol. 37, no. 5, pp. 1105–1114. https://doi.org/10.1007/s00198-026-08008-3

20. Sinha T., Mushtaq M.M., Ali H. et al. Vitamin D receptor (VDR) gene polymorphisms and high-turnover renal osteodystrophy or secondary hyperparathyroidism in end-stage renal disease: a systematic review. Cureus, 2024, vol. 16, no. 7, art. e64925. https://doi.org/10.7759/cureus.64925

22. Spoladore R., Ciampi C.M., Ossola P. et al. Heart failure and osteoporosis: shared challenges in the aging population. Journal of Cardiovascular Development and Disease, 2025, vol. 12, no. 2, art. 69. https://doi.org/10.3390/jcdd12020069

23. Uitterlinden A.G., Fang Y., van Meurs J.B., Pols H.A., van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene, 2004, vol. 338, no. 2, pp. 143–156.

24. Verheyen N., Schmid J., Kolesnik E. et al. Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction. ESC Heart Failure, 2024, vol. 11, no. 3, pp. 1730–1738. https://doi.org/10.1002/ehf2.14741

25. Whitlock R.H., Leslie W.D., Shaw J. et al. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease. Kidney International, 2019, vol. 95, no. 2, pp. 447–454. https://doi.org/10.1016/j.kint.2018.09.022

26. Wu Q., Dai J., Liu J. et al. Bridging genomic research disparities in osteoporosis GWAS: insights for diverse populations. Current Osteoporosis Reports, 2025, vol. 23, no. 1, art. 24. https://doi.org/10.1007/s11914-025-00917-2